Johnson & Johnson fined in France for smearing rivals
Credit: flickr/Jamie
France’s competition enforcer has fined Johnson & Johnson subsidiary Janssen-Cilag €25 million after finding the company delayed the availability of low-cost generic versions of one of its painkillers, through both pressure on pharmaceutical regulators and a disparaging and misleading marketing campaign.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Subscribe now